Company / Interest Expense
OMEROS CORP Interest Expense History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$30.8M
FY2023
5-year range
$19.7M / $30.8M
FY2019-FY2023
Trend
+35.9%
vs FY2022
Sector context
#17 of 44
Health Care
What the data says
At $31M, OMEROS CORP's interest expense ranks #28 of 44 in the Health Care sector. Increased from $20M to $31M over the past 2 years.
Based on SEC 10-K filings.
$31M in FY2023 with a 5-year CAGR of +13.7%.
Increased from $20M to $31M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +4.9%
- 5-Year CAGR
- +13.7%
- 10-Year CAGR
- -
Sector benchmark
#28 of 44 in Health CareTop 61% of 44This company $30.8M Sector average $291.0M
▼
-89.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +13.7%, indicating consistent growth.
- In FY2023, interest expense increased 35.9% year-over-year.
- Ranks #17 out of 44 companies in the Health Care sector.
- Lowest interest expense in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | $30.8M | +35.9% |
| FY2022 | $22.7M | +15.4% |
| FY2021 | $19.7M | -26.5% |
| FY2020 | $26.8M | +18.1% |
| FY2019 | $22.7M | +39.4% |
| FY2018 | $16.3M | +47.3% |
| FY2017 | $11.0M | +41.1% |
| FY2016 | $7.8M | +230.5% |
| FY2015 | $2.4M | -31.8% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026